Pulmonary function changes after nebulised and intravenous frusemide in ventilated premature infants
Open Access
- 1 July 1997
- journal article
- clinical trial
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 77 (1) , F32-F35
Abstract
AIMS To compare the effects of a single dose of frusemide administered either intravenously or by nebulisation on pulmonary mechanics in premature infants with evolving chronic lung disease. METHODS The effect of frusemide on pulmonary mechanics was studied at a median postnatal age of 23 (range 14–52) days in 19 premature infants at 24 to 30 weeks gestational age, who had been dependent on mechanical ventilation since birth. Frusemide (1 mg/kg/body weight) was administered, in random order, intravenously and by nebulisation, on two separate occasions 24 hours apart. Pulmonary function studies were performed before and at 30, 60, and 120 minutes after administration of frusemide. Urine was collected for six hours immediately before and for six hours after administration of frusemide. RESULTS Nebulised frusemide increased the tidal volume 31(SE 11.5)% and compliance 34 (SE 12)% after two hours, whereas no change in either was noted for up to two hours after intravenous frusemide administration. Neither intravenous nor nebulised frusemide had any effect on airway resistance. Six hour urine output increased from a mean (SE) of 3.3 (0.4) ml/kg/hour to 5.9 (0.8) ml/kg/hour following intravenous frusemide administration while nebulised frusemide had no effect on urine output. Urinary sodium, potassium, and chloride losses were also significantly higher after intravenous frusemide, whereas nebulised frusemide did not increase urinary electrolyte losses. CONCLUSION Single dose nebulised frusemide improves pulmonary function in premature infants with evolving chronic lung disease without adverse effects on fluid and electrolyte balance.Keywords
This publication has 21 references indexed in Scilit:
- Nebulized furosemide in infants with bronchopulmonary dysplasiaThe Journal of Pediatrics, 1994
- Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids.Thorax, 1992
- Urinalysis: Direct Versus Diaper CollectionClinical Pediatrics, 1991
- Inhibition by Furosemide of Inflammatory Mediators from Lung FragmentsNew England Journal of Medicine, 1991
- Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasiaThe Journal of Pediatrics, 1990
- Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysisPediatric Pulmonology, 1988
- Pulmonary and Renal Responses to Furosemide in Infants With Stage III-IV Bronchopulmonary DysplasiaArchives of Pediatrics & Adolescent Medicine, 1985
- Maximum diuresis—a factor in predicting recovery from respiratory distress syndrome and the development of bronchopulmonary dysplasiaThe Journal of Pediatrics, 1981
- Effect of furosemide in canine low-pressure pulmonary edema.Journal of Clinical Investigation, 1979
- Bronchopulmonary dysplasia: Possible relationship to pulmonary edemaThe Journal of Pediatrics, 1978